IN FISCAL 4/30/25, ACGT FUNDED CLINICAL INVESTIGATOR GRANTS AWARDED TO INNOVATIVE SCIENTISTS CONDUCTING TRANSLATIONAL RESEARCH AT PREMIER ACADEMIC INSTITUTIONS IN THE U.S., EACH FOCUSING ON THE DEVELOPMENT OF CANCER CELL AND GENE THERAPIES FOR DIFFERENT CANCERS, INCLUDING PANCREATIC, PEDIATRIC, AND BRAIN CANCERS, AND CANCER METASTASIS. ACGT CONTINUED MULTI-YEAR COLLABORATIONS WITH MULTI-DISCIPLINARY 501(C)(3) ORGANIZATIONS FOCUSED ON CELL AND GENE THERAPY RESEARCH. ACGT FURTHER CONVENED ITS ANNUAL SCIENTIFIC SUMMIT AND ALSO INCREASED PUBLIC AWARENESS OF CELL AND GENE THERAPY RESEARCH THROUGH ACGT'S WEBSITE, SOCIAL MEDIA, AND IMPACT REPORTS.
